Acute Myeloid Leukaemia (AML) is a heterogeneous blood cancer that accounts for 15-20% of all paediatric acute leukaemia cases. Despite it’s low incidence in children, it is a life-threatening disease.
It has been found that by providing children with a choice of flavoured lip balms to put onto their breathing masks before undergoing operations is beneficial in many ways.
Diffuse intrinsic pontine glioma (DIPG) is a very aggressive tumour that mostly affect young children and is the main cause of brain tumour death in children. Mutations that cause epigenetic alterations have recently been highlighted as the major driver for this tumour.
An OHCF-funded study will help healthcare professionals at GOSH understand the ongoing needs of children who have survived cancer, thereby improving the care they receive as they enter adolescence.
OHCF is supporting significant research into potential new therapies for this very serious form of childhood cancer.
A new, more efficient method of DNA sequencing will help ICH scientists quickly identify causes of bone marrow failure syndromes.
Funds donated by OHCF will enable haematologists at GOSH use a form of DNA sequencing to help them treat and prevent relapse of a common childhood cancer.
A pilot study by the Institute for Child Health aims to understand how a treatment that has generated a response in some adult cancer patients might also have a role in paediatric oncology.